Wendy Chung is a clinical and molecular geneticist who directs the
clinical genetics program at Columbia University and performs human
genetic research. She received her B.A. in biochemistry and
economics from Cornell University, her M.D. from Cornell University
Medical College, and her Ph.D. from The Rockefeller University in
genetics. She directs research programs in human genetics of
complex traits such as obesity, diabetes, breast cancer, and
congenital heart disease. The goal of her research is to identify new
genes for susceptibility to complex genetic traits to develop
individualized risk assessment, prevention, and therapeutic
interventions for these disorders. Clinically, she directs programs in
risk assessment for oncogenetics, cardiomyopathy, arrhythmias, and
diabetes and develops novel molecular diagnostic methods to
improve genetic testing including preimplantation genetic diagnosis.
She enjoys the challenges of genetics as a rapidly changing field of
medicine and the ethical issues posed by research in human
genetics. She lectures and writes often on the legal and social issues
raised by genetic testing in asymptomatic individuals, disparities is
access to genetic care, confidentiality and privacy of genetic
information, and defining conditions for which prenatal genetic testing
is or is not appropriate. She is a recipient of the American Academy
of Pediatrics Young Investigator Award and is currently the Herbert
Irving assistant professor of pediatrics and medicine. She strives to
facilitate the integration of genetic medicine into all areas of health
care in a medically, scientifically, and ethnically sound, accessible, and cost effective manner.
clinical genetics program at Columbia University and performs human
genetic research. She received her B.A. in biochemistry and
economics from Cornell University, her M.D. from Cornell University
Medical College, and her Ph.D. from The Rockefeller University in
genetics. She directs research programs in human genetics of
complex traits such as obesity, diabetes, breast cancer, and
congenital heart disease. The goal of her research is to identify new
genes for susceptibility to complex genetic traits to develop
individualized risk assessment, prevention, and therapeutic
interventions for these disorders. Clinically, she directs programs in
risk assessment for oncogenetics, cardiomyopathy, arrhythmias, and
diabetes and develops novel molecular diagnostic methods to
improve genetic testing including preimplantation genetic diagnosis.
She enjoys the challenges of genetics as a rapidly changing field of
medicine and the ethical issues posed by research in human
genetics. She lectures and writes often on the legal and social issues
raised by genetic testing in asymptomatic individuals, disparities is
access to genetic care, confidentiality and privacy of genetic
information, and defining conditions for which prenatal genetic testing
is or is not appropriate. She is a recipient of the American Academy
of Pediatrics Young Investigator Award and is currently the Herbert
Irving assistant professor of pediatrics and medicine. She strives to
facilitate the integration of genetic medicine into all areas of health
care in a medically, scientifically, and ethnically sound, accessible, and cost effective manner.
Videos (1)
Wendy Chung, MD is associated with the following videos.
